Search results
Showing 1681 to 1695 of 2581 results for methods
Evidence-based recommendations on palbociclib (Ibrance) as initial endocrine-based therapy for hormone-receptor positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic (secondary) breast cancer in adults.
Evidence-based recommendations on Sleepio to treat insomnia and insomnia symptoms.
Discontinued Reference number: GID-MT510
Pertuzumab–trastuzumab with chemotherapy for treating HER2-positive breast cancer [ID2724]
In development Reference number: GID-TA10592 Expected publication date: TBC
In development Reference number: GID-TA10826 Expected publication date: TBC
Intravenous zanamivir for treating influenza in hospital [ID1196]
Discontinued Reference number: GID-TA10298
Discontinued Reference number: GID-TA10332
Belimumab with rituximab for treating systemic lupus erythematosus [ID3967]
Discontinued Reference number: GID-TA10869
Tocilizumab for the treatment of systemic juvenile idiopathic arthritis (TA238)
Evidence-based recommendations on tocilizumab (RoActemra), for treating systemic juvenile idiopathic arthritis in people aged 2 and over.
Evidence-based recommendations on aflibercept (Eylea) for treating sight problems caused by macular oedema from central retinal vein occlusion in adults.
Evidence-based recommendations on anakinra (Kineret) for treating adult-onset Still’s disease and systemic juvenile idiopathic arthritis in people 8 months and older.
Discontinued Reference number: GID-TAG370
Outside interests of the NICE board
Dasatinib for the treatment of acute lymphoblastic leukaemia [ID386]
Discontinued Reference number: GID-TAG399
Prevena incision management system for closed surgical incisions (MIB173)
NICE has developed a medtech innovation briefing (MIB) on Prevena incision management system for closed surgical incisions .